Preintervention (baseline) | Postintervention | |||
Control (n=12) (f=7, m=5) | Trained (n=12) (f=6, m=6) | Control (n=12) (f=7, m=5) | Trained (n=12) (f=6, m=6) | |
Aerobic fitness indicators | ||||
HR peak (beats.min−1) | 196 (12) | 196 (09) | 197 (16) | 198 (12) |
RER peak | 1.1 (0.1) | 1.1 (0.3) | 1.1 (0.3) | 1.1 (0.2) |
VO2max (L.min−1) | 2.3 (0.3) | 2.2 (0.4) | 2.3 (0.4) | 2.3 (0.1) |
VO2max (mL.min−1.kg−1) | 23.4 (8.4) | 22.6 (6.4) | 22.2 (7.4) | 23.1 (6.1) |
Metabolic analysis | ||||
Glucose (mmol/L) | 4.61 (0.11) | 4.64 (0.12) | 4.64 (0.15) | 4.32 (0.22)** |
Insulin (µmol/mL) | 22.6 (4.6) | 23.2 (4.6) | 23.2 (4.6) | 13.8 (3.3)** |
HOMA-IR | 4.63 (1.7) | 4.78 (1.2) | 4.78 (1.2) | 2.65 (1.5)** |
Lipid contribution (%) | ||||
Rest | 58 (10) | 57 (9) | 57 (11) | 68 (4)** |
25 W | 47 (9) | 47 (8) | 48 (10) | 73 (13)** |
50 W | 23 (5) | 24 (5) | 24 (5) | 45 (5)** |
75 W | 11(2) | 11(4) | 11(4) | 25(2)** |
Values are mean±SD.
**p<0.01; significant difference from baseline.
f, female; HOMA-IR, homoeostasis model assessment index of insulin resistance; HR, heart rate; m, men; RER, respiratory exchange ratio; VO2max, maximal oxygen consumption.